Global Needle Free Injection Systems Market
Market Size in USD Billion
CAGR : %
Forecast Period |
2023 –2030 |
Market Size (Base Year) |
USD 156.00 Million |
Market Size (Forecast Year) |
USD 670.77 Million |
CAGR |
|
Major Markets Players |
|
Global Needle Free Injection Systems Market, By Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors, Powder-Based Needle Free Injectors), Product (Fillable Needle-Free Injectors, Prefilled Needle-Free Injectors), Technology (Jet-Based Needle-Free Injectors, Spring Global Needle Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Usability (Disposable Needle-Free Injectors, Reusable Needle-Free Injectors), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Other), End User (Hospitals and Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Other) - Industry Trends and Forecast to 2030.
Needle Free Injection Systems Market Analysis and Size
Needle-free injection systems are used to administer liquid formulations, drugs, and vaccines into patients without piercing the skin with a conventional needle. The demand for these systems has increased considerably in the recent years as they improve immune response to vaccines, eliminate risks of needles, and reduce healthcare costs.
Data Bridge Market Research analyses that the Needle Free Injection Systems market which was USD 156.00 million in 2022, is expected to reach USD 670.77 million by 2030, and is expected to undergo a CAGR of 20.00% during the forecast period. This indicates the market value. Liquid-based needle-free injectors dominates the type segment of the needle free injection systems market owing to the growing demand for drug administration. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Needle Free Injection Systems Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015-2020) |
Quantitative Units |
Revenue in USD Million, Volumes in Units, and Pricing in USD |
Segments Covered |
By Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors, Powder-Based Needle Free Injectors), Product (Fillable Needle-Free Injectors, Prefilled Needle-Free Injectors), Technology (Jet-Based Needle-Free Injectors, Spring Global Needle Free Injectors, Laser-Powered Needle-Free Injectors, Vibration-Based Needle-Free Injectors), Usability (Disposable Needle-Free Injectors, Reusable Needle-Free Injectors), Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, Intradermal Injectors), Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Other), End User (Hospitals and Clinics, Home Care Settings, Research Laboratories, Pharmaceutical and Biotechnological Companies, Other) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
PharmaJet (U.S.), Portal Instruments (U.S.), Medical International Technology, Inc (U.S.), NuGen Medical Devices (Canada), Crossject SA (U.S.), Antares Pharma (U.S.), 3M (U.S.), Injex Pharma AG(Germany), NovaXS Biotech (U.S.) and INVIO Pharmaceutical Inc. (U.S.) |
Market Opportunities |
|
Market Definition
Needle-free injection systems are used to administer liquid formulations, drugs, and vaccines into patients without piercing the skin with a conventional needle. The demand for these systems has increased considerably in the recent years as they improve immune response to vaccines, eliminate risks of needles, and reduce healthcare costs. However, lack of skilled professionals and the restricted use of needle-free injection systems for intravenous administration impede the market growth.
Global Needle Free Injection Systems Market Dynamics
Drivers
- Growing Prevalence of Patients and Promote Treatment to Boost Market Growth
Drugs are supposed to be administered into the body without using injection needle as conveniently and painlessly as feasible. Needle free injection systems used to give medications for the treatment of many different conditions. It is estimated that over the forecasted period, the value of the needle free injection system market would increase due to the increased prevalence of chronic diseases including osteoporosis and diabetes.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle
- Research and Development Proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to medical devices and advance products will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments is also expected to drive the market growth rate.
When developing drug-delivery device systems, it is important to identify equipment that can efficiently perform all of the required product testing while intelligently capturing and evaluating the test data in accordance with government regulations. The test system must also be flexible and modular enough that manufacturers can change and add functionality over time.
- Increasing Government Initiatives for Improving Healthcare
Healthcare sector is increasing rapidly, which have a significant impact on public health as well as economic activity. The increasing government initiatives for advance systems enhance the demand for the Needle Free Injection Systems. The use of Needle Free Injection Systems is increasing in households, hospitals and independent laboratory.
When developing and mass producing such devices, manufacturers usually perform a combination of testing to government-regulated standards and internal quality testing to ensure efficacy of the device. Internal quality testing is often necessary because the international standards committees cannot always amend testing standards as quickly as the device technology evolves.
Opportunities
- Increasing Demand for Painless Drug Delivery
Needle-free injections provide a painless alternative to traditional needle injections, which can be particularly beneficial for patients who have a fear of needles or experience discomfort during injections. The market is expected to grow as more individuals seek painless drug delivery options.
- Expansion of Vaccination Programs
Needle-free injection systems are also being widely adopted in vaccination programs, particularly in developing countries. They offer advantages such as reduced cross-contamination risk and improved vaccine coverage. As global vaccination programs continue to expand, the demand for needle-free injection devices is expected to rise.
Restraints/Challenges
- Limited Awareness and Acceptance
The needle-free injection technology is still relatively new and not as widely known or accepted compared to traditional needle injections. Healthcare providers and patients may have concerns about the efficacy, safety, and reliability of these devices, which could hinder their adoption.
- High Cost of Products
Needle-free injection devices can be more expensive compared to traditional needle-based injection systems. The initial investment and ongoing maintenance costs associated with these devices may limit their adoption, particularly in low-income regions or healthcare settings with budget constraints.
This Needle Free Injection Systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global needle free injection systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In March 2022, NovaXS Biotech launch injection therapy needle-free such as NovaXS Biotech wants to make injection therapy needle-free
- In December 2021, PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next-generation DNA-based COVID-19 vaccine candidates
- In August 2021, PharmaJet partner Zydus Cadila announced Emergency Use Authorization approval for worlds first plasmid DNA COVID-19 vaccine deliver via needle-free injection
Global Needle Free Injection Systems Market Scope
The Needle Free Injection Systems market is segmented on the type, product, technology, usability, site of delivery, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Liquid-Based Needle-Free Injectors
- Projectile/Depot-Based Needle-Free Injectors
- Powder-Based Needle Free Injectors
Product
- Fillable Needle-Free Injectors
- Prefilled Needle-Free Injectors
Technology
- Jet-Based Needle-Free Injectors
- Spring Global Needle Free Injectors
- Laser-Powered Needle-Free Injectors
- Vibration-Based Needle-Free Injectors
Usability
- Disposable Needle-Free Injectors
- Reusable Needle-Free Injectors
Site of Delivery
- Subcutaneous Injectors
- Intramuscular Injectors
- Intradermal Injectors
Application
- Vaccine Delivery
- Insulin Delivery
- Oncology
- Pain Management
- Other
End User
- Hospitals and Clinics
- Home Care Settings
- Research Laboratories
- Pharmaceutical and Biotechnological Companies
- Other
Global Needle Free Injection Systems Market Regional Analysis/Insights
The global Needle Free Injection Systems market is analysed and market size insights and trends are provided by country, type, product, technology, usability, site of delivery, application and end user as referenced above.
The countries covered in the Needle Free Injection Systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the global needle free injection systems market because of the strong base of healthcare facilities, the strong presence of major players in the market increases cases of chronic diseases, and the rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global needle free injection systems market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global needle free injection systems market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global needle free injection systems market. The data is available for the historic period 2015-2020.
Competitive Landscape and Global Needle Free Injection Systems Market Share Analysis
The global needle free injection systems market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global needle free injection systems market.
Some of the major players operating in the global needle free injection systems market are:
- PharmaJet (U.S.)
- Portal Instruments (U.S.)
- Medical International Technology, Inc (U.S.)
- NuGen Medical Devices (Canada)
- Crossject SA (U.S.)
- Antares Pharma (U.S.)
- 3M (U.S.)
- Injex Pharma AG (Germany)
- NovaXS Biotech (U.S.)
- INVIO Pharmaceutical Inc. (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.